State Street’s Matinas BioPharma MTNB Stock Holding History

State Street’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.38K	Hold	1,021	–	–	﹤0.01%	4250
2026 Q1	$7.66K	Hold	1,021	–	–	﹤0.01%	4259
2025 Q4	$8.98K	Hold	1,021	–	–	﹤0.01%	4272
2025 Q3	$29K	Hold	1,021	–	–	﹤0.01%	4217
2025 Q2	$13.6K	Hold	1,021	–	–	﹤0.01%	4228
2025 Q1	$7.97K	Hold	1,021	–	–	﹤0.01%	4259
2024 Q4	$7.81K	Hold	1,021	–	–	﹤0.01%	4283
2024 Q3	$54.2K	Hold	1,021	–	–	﹤0.01%	4087
2024 Q2	$121K	Buy	1,021 +141	+16%	+$19.2K	﹤0.01%	3952
2024 Q1	$179K	Sell	880 -70	-7%	-$12.5K	﹤0.01%	3895
2023 Q4	$154K	Hold	950	–	–	﹤0.01%	3949
2023 Q3	$92.6K	Hold	950	–	–	﹤0.01%	4131
2023 Q2	$256K	Hold	950	–	–	﹤0.01%	3925
2023 Q1	$335K	Hold	950	–	–	﹤0.01%	3887
2022 Q4	$356K	Hold	950	–	–	﹤0.01%	3886
2022 Q3	$453K	Hold	950	–	–	﹤0.01%	3813
2022 Q2	$563K	Hold	950	–	–	﹤0.01%	3785
2022 Q1	$573K	Buy	950 +71	+8%	+$39.2K	﹤0.01%	3987
2021 Q4	$666K	Hold	879	–	–	﹤0.01%	3914
2021 Q3	$857K	Hold	879	–	–	﹤0.01%	3813
2021 Q2	$511K	Buy	879 +699	+388%	+$451K	﹤0.01%	3845
2021 Q1	$142K	Buy	180 +11	+7%	+$11.1K	﹤0.01%	3874
2020 Q4	$172K	Hold	169	–	–	﹤0.01%	3767
2020 Q3	$97K	Hold	169	–	–	﹤0.01%	3722
2020 Q2	$98K	Hold	169	–	–	﹤0.01%	3661
2020 Q1	$76K	Buy	169 +147	+668%	+$133K	﹤0.01%	3639
2019 Q4	$38K	Buy	+22	New	+$19.1K	﹤0.01%	3739
2018 Q3	–	Sell	-68	Closed	-$23K	–	3791
2018 Q2	$23K	Sell	68 -1,086	-94%	-$471K	﹤0.01%	3722
2018 Q1	$664K	Buy	1,154 +27	+2%	+$21.4K	﹤0.01%	3398
2017 Q4	$980K	Sell	1,127 -63	-5%	-$60.8K	﹤0.01%	3355
2017 Q3	$1.18M	Buy	1,190 +301	+34%	+$301K	﹤0.01%	3346
2017 Q2	$1.13M	Buy	+889	New	+$1.79M	﹤0.01%	3315

Other funds holding MTNB

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

State Street's MTNB Position: Q2 2026 in Review

State Street held its Matinas BioPharma (MTNB) position steady in Q2 2026 at 1,021 shares worth $9.38K. The position accounts for ﹤0.01% of the portfolio, ranked #4250.

State Street first reported a position in MTNB in Q2 2017 and has held it in 32 quarters since. The position peaked at $1.18M in Q3 2017. 23 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.

State Street held 1,021 shares of Matinas BioPharma worth $9.38K as of Q2 2026.
State Street left its Matinas BioPharma share count unchanged in Q2 2026.
Matinas BioPharma made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4250 holding.
State Street first reported a position in Matinas BioPharma in Q2 2017 and has held it in 32 quarters since.
State Street's Matinas BioPharma position peaked at $1.18M in Q3 2017.
23 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.